The clinical and economic burden of communityonset complicated skin and skin structure infections in Korea
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: To investigate epidemiologic characteristics, clinical and economic burdens, and factors associated with mortality in complicated skin and skin structure infection (cSSSI) patients in Korea. Methods: A retrospective, observational, nationwide study was conducted between April to July 2012 at 14 tertiary-hospitals in Korea. Eligible patients were hospitalized adults with community acquired cSSSI, who underwent surgical intervention and completed treatment between November 2009 and October 2011. Data on demography, clinical characteristics, outcomes and medical resource utilization were collected through medical record review. Direct medical costs were calculated by multiplying quantities of resources utilized by each unit price in Korea. Results: Of 473 patients enrolled, 449 patients (except 24 patients with no record on surgical intervention) were eligible for analysis. Microbiological testing was performed on 66.1% of patients and 8.2% had multiple pathogens. Among culture confirmed pathogens (n = 297 patients, 340 episodes), 76.2% were gram-positive (Staphylococcus aureus; 41.2%) and 23.8% were gram-negative. The median duration of hospital stay was 16 days. Among treated patients, 3.3% experienced recurrence and 4.2% died in-hospital. The mean direct medical costs amounted to $4,195/ person, with the greatest expenses for hospitalization and antibiotics. The in-hospital mortality and total medical costs were higher in combined antibiotics therapy than monotherapy (p < 0.05). Charlson’s comorbidity index ≥ 3, standardized early warning scoring ≥ 4, sub-fascia infections and combined initial therapy, were all found to be associated with higher mortality. Conclusions: Korean patients with community-onset cSSSI suffer from considerable clinical and economic burden. Efforts should be made to reduce this burden through appropriate initial treatment.
Abstract
Background/Aims: To investigate epidemiologic characteristics, clinical and economic burdens, and factors associated with mortality in complicated skin and skin structure infection (cSSSI) patients in Korea. Methods: A retrospective, observational, nationwide study was conducted between April to July 2012 at 14 tertiary-hospitals in Korea. Eligible patients were hospitalized adults with community acquired cSSSI, who underwent surgical intervention and completed treatment between November 2009 and October 2011. Data on demography, clinical characteristics, outcomes and medical resource utilization were collected through medical record review. Direct medical costs were calculated by multiplying quantities of resources utilized by each unit price in Korea. Results: Of 473 patients enrolled, 449 patients (except 24 patients with no record on surgical intervention) were eligible for analysis. Microbiological testing was performed on 66.1% of patients and 8.2% had multiple pathogens. Among culture confirmed pathogens (n = 297 patients, 340 episodes), 76.2% were gram-positive (Staphylococcus aureus; 41.2%) and 23.8% were gram-negative. The median duration of hospital stay was 16 days. Among treated patients, 3.3% experienced recurrence and 4.2% died in-hospital. The mean direct medical costs amounted to $4,195/ person, with the greatest expenses for hospitalization and antibiotics. The in-hospital mortality and total medical costs were higher in combined antibiotics therapy than monotherapy (p < 0.05). Charlson’s comorbidity index ≥ 3, standardized early warning scoring ≥ 4, sub-fascia infections and combined initial therapy, were all found to be associated with higher mortality. Conclusions: Korean patients with community-onset cSSSI suffer from considerable clinical and economic burden. Efforts should be made to reduce this burden through appropriate initial treatment.
참고문헌 (13)
- Stevens DL, "Practice guidelines for the diagnosis and management of skin and soft tissue infections : 2014 update by the Infectious Diseases Society of America", Clin Infect Dis, 59, pp.e10~e52 (2014)
- Guidance for Industry: Uncomplicated and Complicated Skin and Skin Structure Infections—Developing Antimicrobial Drugs for Treatment, "Center for Drug Evaluation and Research", Food and Drug Administration, US Department of Health and Human Services, ~ (1998)
- May AK, "Treatment of complicated skin and soft tissue infections", Surg Infect(Larchmt), 10, pp.467~499 (2009)
- Nichols RL, "Optimal treatment of complicated skin and skin structure infections", J Antimicrob Chemother, 44, pp.19~23 (1999)
- DiNubile MJ, "Complicated infections of skin and skin structures : when the infection is more than skin deep", J Antimicrob Chemother, 53, pp.ii37~ii50 (2004)
- Doern GV, "Bacterial pathogens isolated from patients with skin and soft tissue infections: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997). SENTRY Study Group (North America)", Diagn Microbiol Infect Dis, 34, pp.65~72 (1999)
- Lee SY, "Antimicrobial management of complicated skin and skin structure infections in the era of emerging resistance", Surg Infect(Larchmt), 6, pp.283~295 (2005)
- Hook EW 3rd, "Microbiologic evaluation of cutaneous cellulitis in adults", Arch Intern Med, 146, pp.295~297 (1986)
- McHenry CR, "Determinants of mortality for necrotizing soft-tissue infections", Ann Surg, 221, pp.558~563 (1995)
- Garau J, "Current management of patients hospitalized with complicated skin and soft tissue infections across Europe (2010-2011): assessment of clinical practice patterns and real-life effectiveness of antibiotics from the REACH study", Clin Microbiol Infect, 19, pp.E377~E385 (2013)
- Itani KM, "Outcomes and management costs in patients hospitalized for skin and skin-structure infections", Am J Infect Control, 39, pp.42~49 (2011)
- Zilberberg MD, "Epidemiology and outcomes of hospitalizations with complicated skin and skin-structure infections : implications of healthcare-associated infection risk factors", Infect Control Hosp Epidemiol, 30, pp.1203~1210 (2009)
- Edelsberg J, "Clinical and economic consequences of failure of initial antibiotic therapy for hospitalized patients with complicated skin and skin-structure infections", Infect Control Hosp Epidemiol, 29, pp.160~169 (2008)